Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.
about
Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-AnalysisHepatitis C genotype 4: The past, present, and futureMonoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusBurden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010Injection Drug Use Is a Risk Factor for HCV Infection in Urban EgyptHepatitis C Virus in North Africa: An Emerging ThreatThe Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-AnalysisHepatitis C virus infection.A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugsKnowledge and perceptions of hepatitis C infection and pesticides use in two rural villages in EgyptCross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Hepatocellular carcinoma in the world and the middle East.Cancer incidence in egypt: results of the national population-based cancer registry programHepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan.New insight into HCV E1/E2 region of genotype 4a.Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in PolandProspective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patientsHepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patientsPhylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients.Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapyTumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patientsCorrelation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.Heterogeneity and new epitopes of hepatitis C virus genotype 4.Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt.Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern Iraq.Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.Can brucellosis influence the course of chronic hepatitis C in dual infection?Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus.
P2860
Q26747679-E291E65E-6B65-42FA-B5FA-A47B76A0FF10Q26775815-3EBFB675-45F3-419D-9C0F-FEE732C824F7Q26783378-9E16D548-F8F6-4705-8FCA-1F81E97461B2Q27000368-326F9908-55A9-426E-B06E-6EEF83D88B1DQ27489633-BA97E8CF-E3E5-45DD-BC49-7CCD54904C33Q28069590-BCF2D3DB-F5D3-423C-AEC2-14BF00CA7706Q28076929-C59B51E7-88D7-4E1E-94F6-CD08FC4DD310Q30235491-D8F067E0-BCD1-4067-81F2-C4B5025A125DQ30403548-1DAE393A-4144-492A-A51A-4D4B83ACE4F5Q33618436-45A39E28-30F8-4A88-AA22-22CC86A22985Q33729947-57BE28DD-B615-49C0-9602-FF4859A1FC7FQ33826033-592536ED-2135-4111-BE9A-CBFC0792F01BQ34134967-8CDDAA2A-79A6-4109-BB88-F0809FEF0029Q34307432-62D3B25C-4820-4BFF-8E0C-5881695403E8Q34522014-51ABCDCA-FEA6-4EB7-BA92-446B0BFC6DDEQ35005196-9D291D09-5EB6-4BDE-A554-8D4372DAE213Q35238151-AA30E1CB-9B07-49AF-B01E-EE01E476D53BQ35507630-86DFC3EC-2615-4006-8284-2A9BAADBCACAQ35606486-61E78428-61DD-4BCD-8E0A-6C7A5D74FA88Q35990080-1A5F12A6-9D38-41BA-A6AB-F08BA6E39B03Q36158361-399C590F-B847-4DEE-8B89-379D79120386Q36336416-28A9FAA1-EC98-465B-BA19-3D76BBFDE7E0Q36414090-3C2527BB-963B-4920-9BDE-148C24B41514Q36626705-805C6446-D5CA-4FAA-89CE-99F6DB8B374FQ36702487-0F0D813B-0D4E-4198-856E-F63C57782B60Q36871894-85AE828D-F1FC-4887-9A30-68552CC8AD86Q36888680-7F3254E2-C80D-4101-AE95-7EABBC6C1C6CQ37063664-0D9A1425-CCE3-425B-A211-48EC45F4EB12Q37183637-22B8BAEF-9107-4838-89E7-A8437F1FA891Q37199380-EC143749-5F9C-4224-8022-2759C4372336Q37228726-EBF4ABBF-C14E-4CEF-8B3E-04BE6D4FCEF2Q37401168-E5BEDF54-A2F1-4D88-8775-83235A90B878Q37618613-E412140D-97DD-482C-8136-93F7DDED5BADQ37975114-AAF61581-FF7C-433B-A918-A22ED74E1FD5Q38164114-EA6EBBAE-DA94-4676-9A47-DDF6C0A6EE3CQ38203033-E2EDEC90-C7F5-4CEC-ABC1-1A570061DC00Q38856008-EB476792-EB21-4EF4-9BD9-0427F246641FQ38857465-10CE7158-6932-4324-9AA7-C9F454BFA1E0Q39141504-2F8B0A4D-FD1E-44BD-9E8E-220E5094EEBCQ40035372-8C67FB1D-9DB0-4C2A-8BD7-513E7D0B330D
P2860
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic diversity in hepatitis ...... with hepatocellular carcinoma.
@en
type
label
Genetic diversity in hepatitis ...... with hepatocellular carcinoma.
@en
prefLabel
Genetic diversity in hepatitis ...... with hepatocellular carcinoma.
@en
P2093
P356
P1476
Genetic diversity in hepatitis ...... with hepatocellular carcinoma.
@en
P2093
Anders Widell
Christopher Loffredo
G Thomas Strickland
Gamal Esmat
Jan Albert
Mai El-Daly
Mohamed Abdel-Hamid
Sherif El-Kafrawy
Sohair Abdel-Latif
Vilma Molnegren
P304
P356
10.1099/VIR.0.82626-0
P407
P577
2007-05-01T00:00:00Z